Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study)

CompletedOBSERVATIONAL
Enrollment

35,921

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
General Safety Profile of DOTAREM
Trial Locations (10)

Unknown

Hospital Italiano de Buenos Aires, Buenos Aires

Diagnosticum Gersthof, Vienna

Shanghai Pulmonary Hospital, Shanghai

Hôpital Necker, Paris

Universitätskliniken, Cologne

Bombay Hospital Institute of Medical Sciences, Mumbai

Ospedale Policlinico Giambattista Rossi, Verona

Tabouk Military Hospital, Tabuk

Complexo Hospitalario Xeral-Calde, Lugo

Hull Royal Infirmary, Hull

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Guerbet

INDUSTRY

NCT01523873 - Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study) | Biotech Hunter | Biotech Hunter